期刊文献+

2004-2006年铜陵市2家医院非甾体抗炎药利用分析 被引量:2

Analysis on the Use of Non-steroidal Anti-inflammatory Drugs in Two Hospitals in Tongling City During 2004~2006
原文传递
导出
摘要 目的:评价非甾体抗炎药(NSAIDs)的利用现状及趋势。方法:采用频度分析法对安徽铜陵市2家医院2004-2006年NSAIDs的种类、用药频度、销售金额进行统计、分析。结果:NSAIDs的用药频度逐年增长,年均增幅达7.07%;销售金额2005年增长4.15%,2006年下跌4.94%,个别新型NSAIDs销售金额增幅明显。结论:NSAIDs的用药结构在今后几年内不会有太大变化,但不良反应问题应引起广泛重视。 OBJECTIVE : To evaluate the utilization status and the developmental trend of non - steroidal anti - inflammatory drugs(NSAIDs) in our clty.METHODS: NSAIDs used in two hospitals in Anhui Tongling city during 2004--2006 were analyzed statistically in respect of drug varieties, DDDs and consumption sum. RESULTS: The DDDs of NSAIDs increased, up 7.07% year on year. The consumption of NSAIDs increased by 4.15% in 2005, but decreased by 4.94% in 2006.New type NSAIDs had a great increase in consumption sum.CONCLUSION:The utilization structure of NSAIDs in our city is expected to remain stable in the coming several years,but great attention should be paid to the ADR of NSAIDs.
出处 《中国药房》 CAS CSCD 北大核心 2007年第32期2491-2493,共3页 China Pharmacy
关键词 非甾体抗炎药 用药频度 用药趋势 药品利用 Non - steroidal anti - inflammatory drugs DDDs Trend of drug use Drug use
  • 相关文献

参考文献3

二级参考文献19

  • 1张胜选,董香茂.低分子肝素和阿斯匹林对不稳定型心绞痛的治疗[J].实用临床医学(江西),2002(6):75-76. 被引量:6
  • 2Hao CM,Breyer MD.Hypertension and cyclooxygenase-2 inhibitors:target:the renal medulla.Hypertension,2004,44:396 ~ 397.
  • 3Hermann M,Shaw S,Kiss E,et al.Selective COX-2 inhibitors and renal injury in salt-sensitive hypertension.Hypertension,2005,5:193 ~ 196.
  • 4Solomon D,Schneeweiss S,Levin R,et al.Relationship between COX-2 specific inhibitors and hypertension.Hypertension,2004,44:140~145.
  • 5Delgado RM,Nawar MA,Zewail AM,et al.Cyclooxygenase-2 inhibitor treatment improves left ventricular function and mortality in a murine model of doxorubicin-induced heart failure.Circulation,2004,109:1428~1433.
  • 6Witters LM,Crispino J,Fraterrigo T,et al.Effect of the combination of docetaxel,zoledronic acid,and a COX-2 inhibitor on the growth of human breast cancer cell Lines.American Journal of Clinical Oncology,2003 ;26 (4) Supplement 2:S92 ~ S97.
  • 7Saha D,Pyo H,Choy H.COX-2 inhibitor as a radiation enhancer:new strategies for the treatment of lung cancer.American Journal of Clinical Oncology,2003,26 (4) Supplement 2:S70 ~S74.
  • 8Gopez JJ,Yue HF,Vasudevan R,et al.Cyclooxygenase-2-specific inhibitor improves functional outcomes,provides neuroprotection,and reduces inflammation in a rat model of traumatic brain injury.Neurosurgery,2005,56:590 ~604.
  • 9Iadecola C,Gorelick PB.The janus face of cyclooxygenase-2 in ischemic stroke:shifting toward downstream targets.Stroke,2005,36:182 ~185.
  • 10Yamamoto T,Sakashita Y.COX-2 inhibitor prevents the development of hyperalgesia induced by intrathecal NMDA or AMPA.Neuroreport,1998,9:3869 ~ 3873.

共引文献12

同被引文献8

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部